BioCardia, Inc. Other Nonoperating Expense
BioCardia, Inc. (BCDA) reported Other Nonoperating Expense of $1.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2017-05-11
- BioCardia, Inc. other nonoperating expense for the quarter ending 2017-03-31 was $1.00K.
- BioCardia, Inc. other nonoperating expense for fiscal 2016 was $2.00K, a 0.00% change from fiscal 2015.
- BioCardia, Inc. other nonoperating expense for fiscal 2015 was $2.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 12 month |
|---|---|---|
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $2.00K 10-K · filed 2017-03-30 | |
| 2015-12-31 | $2.00K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |